Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Multiple Myeloma 4Neoplasms, Plasma Cell 3Colorectal Neoplasms 3Hematologic Neoplasms 2Frailty 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Upper Excretory Tract Tumors 1Transfusion-Related Acute Lung Injury 1Thrombosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sezary Syndrome 1Sarcopenia 1Sarcoglycanopathies 1Psoriasis 1Peripheral Arterial Disease 1Patient Acceptance of Health Care 1Ovarian Neoplasms 1Myocardial Infarction 1Myeloproliferative Disorders 1Mycoses 1Melanoma 1Malnutrition 1

Interventions

Temozolomide 12Magnetic Resonance Spectroscopy 9Radiotherapy 6Surveys and Questionnaires 5Blood Specimen Collection 4Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Radiation 3Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Lomustine 2Immunotherapy 2Drug Therapy 2Chemoradiotherapy 2Amplified Fragment Length Polymorphism Analysis 2regorafenib 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadodiamide 1apatinib 1Ultrasonography 1Trail Making Test 1Therapies, Investigational 1Tablets 1Standard of Care 1Specimen Handling 1Sampling Studies 1Re-Irradiation 1Quality of Life 1Psychometrics 1Proton Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Glioblastoma × Standard of Care × Clear all
NCT04926168 2022-08-10

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Withdrawn
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡